SGI-1027

CAS No. 1020149-73-8

SGI-1027( SGI1027 | SGI 1027 )

Catalog No. M10094 CAS No. 1020149-73-8

SGI-1027 (SGI1027) is a potent inhibitor of DNA methyltransferase (DNMT) with IC50s of 6-12.5 uM for DNMT1, DNMT3A, and DNMT3B.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 48 In Stock
10MG 86 In Stock
25MG 149 In Stock
50MG 281 In Stock
100MG 443 In Stock
500MG 981 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    SGI-1027
  • Note
    Research use only, not for human use.
  • Brief Description
    SGI-1027 (SGI1027) is a potent inhibitor of DNA methyltransferase (DNMT) with IC50s of 6-12.5 uM for DNMT1, DNMT3A, and DNMT3B.
  • Description
    SGI-1027 (SGI1027) is a potent inhibitor of DNA methyltransferase (DNMT) with IC50s of 6-12.5 uM for DNMT1, DNMT3A, and DNMT3B; induces selective degradation of DNMT1 with minimal or no effects on DNMT3A and DNMT3B in different cancer cell lines.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    SGI1027 | SGI 1027
  • Pathway
    Chromatin/Epigenetic
  • Target
    DNMT
  • Recptor
    DNMT1|DNMT3A|DNMT3B
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1020149-73-8
  • Formula Weight
    461.5178
  • Molecular Formula
    C27H23N7O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 27 mg/mL
  • SMILES
    O=C(NC1=CC=C(NC2=NC(N)=NC(C)=C2)C=C1)C3=CC=C(NC4=CC=NC5=CC=CC=C45)C=C3
  • Chemical Name
    Benzamide, N-[4-[(2-amino-6-methyl-4-pyrimidinyl)amino]phenyl]-4-(4-quinolinylamino)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Datta J, et al. Cancer Res. 2009 May 15;69(10):4277-85. 2. Rilova E, et al. ChemMedChem. 2014 Mar;9(3):590-601.
molnova catalog
related products
  • AA-CW236

    A potent, selective, non-pseudosubstrate inhibitor of O(6) -alkylguanine DNA methyltransferase (MGMT) with low-nanomolar potency.

  • Dacogen

    Decitabine is indicated for treatment of patients with myelodysplastic syndrome (MDS).

  • RG108

    RG108 is an inhibitor of DNA methyltransferase with IC50 of 115 nM in a cell-free assay, does not cause trapping of covalent enzymes.